Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Erlanson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nephron|January 1, 1985
Replacement therapy in terminal renal failure in Sweden 1975-1981. What resources will be needed in the future?P Erlanson
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Quinton-Scribner arteriovenous shunts for hemodialysis. A review of 6.5 years' experienceM Lundberg, P Erlanson, R Larsson
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysisR Larsson, P Erlanson, G Bodemar, et al.
British Journal of Clinical Pharmacology|February 1, 1982
The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal functionR Larsson, P Erlanson, G Bodemar, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1986
The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritisS Eriksson, J Zbornik, H Dahnsjö, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nephron|January 1, 1985
Replacement therapy in terminal renal failure in Sweden 1975-1981. What resources will be needed in the future?P Erlanson
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Quinton-Scribner arteriovenous shunts for hemodialysis. A review of 6.5 years' experienceM Lundberg, P Erlanson, R Larsson
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysisR Larsson, P Erlanson, G Bodemar, et al.
British Journal of Clinical Pharmacology|February 1, 1982
The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal functionR Larsson, P Erlanson, G Bodemar, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1986
The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritisS Eriksson, J Zbornik, H Dahnsjö, et al.
Pageof 1